ProstaLund AB Cash Flow Conversion Efficiency

Latest as of June 2025: -0.052x

ProstaLund AB cash flow conversion efficiency. Based on the latest financial reports, ProstaLund AB (PLUN) has a cash flow conversion efficiency ratio of -0.052x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.31 Million ≈ $-248.27K USD) by net assets (Skr44.54 Million ≈ $4.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of ProstaLund AB (2012–2024)

Cash flow conversion efficiency of ProstaLund AB from 2012 to 2024. This chart illustrates how ProstaLund AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest ProstaLund AB stock price today for real-time trading data and today's change.

ProstaLund AB Cash Flow Conversion Ratio Explained

ProstaLund AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

ProstaLund AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ProstaLund AB ranked by their cash flow conversion efficiency. Also see PLUN stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Strikewell Energy Corp V:SKK	0.000x
Kodal Minerals PLC LSE:KOD	-0.035x
Kollect on Demand Holding Ab ST:KOLL	-0.012x
FKS Food Sejahtera Tbk PT JK:AISA	0.005x
CERo Therapeutics Holdings, Inc. Common Stock NASDAQ:CERO	0.076x
Glen Eagle Resources Inc V:GER	0.307x
EUROPA MET. LTD POST CONS F:WRE1	N/A
Onward Opportunities Ltd LSE:ONWD	-0.036x

Annual Cash Flow Conversion Efficiency for ProstaLund AB (2012–2024)

The table below shows the annual cash flow conversion efficiency of ProstaLund AB from 2012 to 2024. Review free cash flow generation of ProstaLund AB to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr55.18 Million ≈ $5.94 Million	Skr-22.59 Million ≈ $-2.43 Million	-0.409x	+4.89%
2023-12-31	Skr55.29 Million ≈ $5.95 Million	Skr-23.80 Million ≈ $-2.56 Million	-0.430x	-10.75%
2022-12-31	Skr41.69 Million ≈ $4.49 Million	Skr-16.20 Million ≈ $-1.74 Million	-0.389x	-137.43%
2021-12-31	Skr35.46 Million ≈ $3.82 Million	Skr-5.80 Million ≈ $-624.60K	-0.164x	+51.64%
2020-12-31	Skr25.35 Million ≈ $2.73 Million	Skr-8.58 Million ≈ $-923.45K	-0.338x	+17.44%
2019-12-31	Skr22.23 Million ≈ $2.39 Million	Skr-9.12 Million ≈ $-980.92K	-0.410x	+56.18%
2018-12-31	Skr12.71 Million ≈ $1.37 Million	Skr-11.89 Million ≈ $-1.28 Million	-0.936x	+20.02%
2017-12-31	Skr13.78 Million ≈ $1.48 Million	Skr-16.11 Million ≈ $-1.73 Million	-1.170x	-150.18%
2016-12-31	Skr30.81 Million ≈ $3.32 Million	Skr-14.41 Million ≈ $-1.55 Million	-0.468x	-11.23%
2015-12-31	Skr23.19 Million ≈ $2.50 Million	Skr-9.75 Million ≈ $-1.05 Million	-0.420x	+53.88%
2014-12-31	Skr11.89 Million ≈ $1.28 Million	Skr-10.83 Million ≈ $-1.17 Million	-0.911x	-23.12%
2013-12-31	Skr5.23 Million ≈ $563.26K	Skr-3.88 Million ≈ $-417.01K	-0.740x	-33.32%
2012-12-31	Skr4.69 Million ≈ $504.83K	Skr-2.60 Million ≈ $-280.34K	-0.555x	--

About ProstaLund AB

ST:PLUN Sweden Medical Care Facilities

Market Cap

$716.78K

Skr6.66 Million SEK

Market Cap Rank

#30864 Global

#716 in Sweden

Share Price

Skr0.21

Change (1 day)

+0.00%

52-Week Range

Skr0.21 - Skr0.21

All Time High

Skr15.54